Skip to main content

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ)

SHZ Healthcare Drug Manufacturers - Specialty & GenericView data quality →
62.4Fair

ValueMarkers Composite Index

Top 86%#6,042 of 44,722
Undervalued

79% below intrinsic value ($19)

UndervaluedFair ValueOvervalued
Piotroski
1/9
Weak
Beneish
-2.51
Low Risk
Altman
-
DCF Value
$19
Undervalued
ROIC
9.0%
Adequate
P/E
13.4
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) — VMCI valuation read

000999.SZ prints VMCI 62/100 inside the Healthcare sector, where the median sits at 50. The 12-point above-median delta is the cleanest single-number summary of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.

On 000999.SZ, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** 000999.SZ trades at 24.0x earnings, 33% above the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of -1.5x leaves covenant headroom; that is the risk line for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. on the trailing financials.

000999.SZ rose 3.7% over the trailing 7 days, with a -6.5% read on a 30-day basis.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.

CEO: Wen Duo Wu20,031 employeesCNwww.999.com.cn

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.